Autoimmune disease
Ọrịa autoimmune bụ ọnọdụ na-esite na nzaghachi mgbochi na-adịghị mma na akụkụ ahụ na-arụ ọrụ [1] E nwere ma ọ dịkarịa ala ụdị ọrịa iri asatọ na-alụso ọrịa ọgụ. Ihe fọrọ nke nta [2] ọ bụrụ akụkụ ahụ ọ bụla nwere ike itinye aka. Mgb[1] ndị a na-ahụkarị gụnyere oke ọkụ na ike ọgwụgwụ. Ọtụtụ mgbe mgbaàmà na-abịa ma na-aga. [1]
[2] Amaghị ihe na akpata ya. Ụfọdụ ọrịa autoimmune [1] ka lupus na-agba ọsọ n'ezinụlọ, na ụfọdụ ikpe nwere ike ibute ọrịa ma ọ bụ ihe ndị ọzọ metụtara gburugburu ebe obibi. Ụfọdụ ọrịa ndị a na-ahụkarị nke a na-ewere n'ozuzu ha dị ka ọrịa na-alụso ọrịa ọgụ gụnyere Ọrịa celiac, ọrịa shuga, Ọrịa Graves, Ọrịa eriri afọ, ọrịa multiple sclerosis, psoriasis, rheumatoid arthritis, na systemic lupus erythematosus.[1][3] [1] nwere ike isi ike ịchọpụta nchọpụta ahụ.
Ọgwụgwọ -adabere na ụdị na ịdị njọ nke ọnọdụ ahụ.. [1] na-ejikarị ọgwụ nonsteroidal anti-inflammatory (NSAIDs) na immunosuppressants eme ihe. [4] pụkwara iji immunoglobulin intravenous mee ihe mgbe ụfọdụ. [1] bụ ezie na ọgwụgwọ na-emekarị ka mgbaàmà dị mma, ha anaghị agwọ ọrịa ahụ.
Ihe dịka ka nde mmadụ iri abụọ na anọ (7%) na United States nwere ọrịa autoimmune[2] [1]Ụmụ nwanyị ka ọ na emetụtakarị karịa ụmụ nwoke. [1] na-amalite mgbe ha toro. [5] kọwara ọrịa mbụ nke autoimmune na mbido afọ 1900.
Edensibia
[dezie | dezie ebe o si]- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 Autoimmune diseases fact sheet. Office on Women's Health. U.S. Department of Health and Human Services (16 July 2012). Archived from the original on 5 October 2016. Retrieved on 5 October 2016.
- ↑ 2.0 2.1 2.2 Borgelt (2010). Women's Health Across the Lifespan: A Pharmacotherapeutic Approach (in en). ASHP. ISBN 978-1-58528-194-7.
- ↑ (February 2016) "The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets". The Lancet. Neurology 15 (2): 198–209. DOI:10.1016/S1474-4422(15)00334-8. PMID 26724103.
- ↑ (2011) "Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases". Current Pharmaceutical Design 17 (29): 3166–75. DOI:10.2174/138161211798157540. PMID 21864262.
- ↑ (2005) Ananthanarayan and Paniker's Textbook of Microbiology (in en). Orient Blackswan. ISBN 9788125028086.